ARID1A and gastric cancer: EBV-positive gastric cancer was frequently identified in ARID1A-negative cases (4 of 16 cases, 25%) compare to ARID1A-positive cases (0 of 21 cases, 0%) (P = 0.028) (Table 1 and Supplementary Fig. S2).